Prothena (LTS:0Y3M) Other Net Income (Loss) : $-0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Prothena Other Net Income (Loss)?

Prothena's Other Net Income (Loss) for the three months ended in Dec. 2024 was $-0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.0 Mil.

Prothena's quarterly Other Net Income (Loss) stayed the same from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil) but then declined from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil).

Prothena Other Net Income (Loss) Historical Data

The historical data trend for Prothena's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prothena Other Net Income (Loss) Chart

Prothena Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Prothena Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Prothena Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.

Prothena Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Prothena's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Prothena Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prothena Corp PLC (LTS:0Y3M) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PRTA:USA

Address

77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, IRL, D02 VK60

Website

https://www.prothena.com

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Prothena Headlines

No Headlines